IDG-Accel China Growth Fund GP III Associates Ltd., 10% Owner at CASI Pharmaceuticals, Inc. (CASI), bought 2,083,332 shares at $2.40 ($5.0M) on 2013-03-07, disclosed to the SEC on 2016-01-27.
Open-market purchase of $5.0M CASI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.40 | 68,958 | $165K | 3.3% |
| 2 | $2.40 | 68,958 | $165K | 3.3% |
| 3 | $2.40 | 972,708 | $2.3M | 46.7% |
| 4 | $2.40 | 972,708 | $2.3M | 46.7% |
| Total | $2.40 avg | 2,083,332 | $5.0M | 100% |